Pfizer’s rheumatoid arthritis medicine ‘effective’ against Covid-19 pneumonia: study
In its latest study, Pfizer found its rheumatoid arthritis drug is effective in Covid-19 patients suffering from respiratory illness. Pfizer Inc said on Wednesday its oral rheumatoid arthritis medicine “Xeljanz”…
Share